Safety Study of Melatonin in Stroke Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.

Also called NCT01863277

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Wolfson Medical Center (from the registry)
Registry
  • NCT NCT01863277
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Israel (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01863277. Randomized; triple masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2014-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety Study of Melatonin in Stroke Patients
Condition
Acute Ischemic Stroke
Intervention (Drug)
Melatonin
Intervention (Drug)
placebo
Lead sponsor
Wolfson Medical Center (class: other government)

Record details

Record id
cardio:ct-nct01863277
Content hash
a4d9a0ddc164a3015941e5ccc106c6b6bc4c34645c39f926223e8a4605237aa7